These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14652863)

  • 1. Comparing Cox and parametric models in clinical studies.
    Nardi A; Schemper M
    Stat Med; 2003 Dec; 22(23):3597-610. PubMed ID: 14652863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric bootstrap for testing model fitting in the proportional hazards framework: an application to the survival analysis of Bruna dels Pirineus beef calves.
    Casellas J; Tarrés J; Piedrafita J; Varona L
    J Anim Sci; 2006 Oct; 84(10):2609-16. PubMed ID: 16971560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development.
    Wang Y; Sung C; Dartois C; Ramchandani R; Booth BP; Rock E; Gobburu J
    Clin Pharmacol Ther; 2009 Aug; 86(2):167-74. PubMed ID: 19440187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
    Royston P; Parmar MK
    Stat Med; 2002 Aug; 21(15):2175-97. PubMed ID: 12210632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of variance in Cox's regression model with shared gamma frailties.
    Andersen PK; Klein JP; Knudsen KM; Tabanera y Palacios R
    Biometrics; 1997 Dec; 53(4):1475-84. PubMed ID: 9423262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Cox model: limitations and extensions].
    Quantin C; Asselain B; Moreau T
    Rev Epidemiol Sante Publique; 1990; 38(4):341-56. PubMed ID: 2287801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parametric modelling of cost data in medical studies.
    Nixon RM; Thompson SG
    Stat Med; 2004 Apr; 23(8):1311-31. PubMed ID: 15083485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible survival regression modelling.
    Cortese G; Scheike TH; Martinussen T
    Stat Methods Med Res; 2010 Feb; 19(1):5-28. PubMed ID: 19608605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer.
    Royston P; Parmar MK; Sylvester R
    Stat Med; 2004 Mar; 23(6):907-26. PubMed ID: 15027080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Cox's and relative survival models when estimating the effects of prognostic factors on disease-specific mortality: a simulation study under proportional excess hazards.
    Le Teuff G; Abrahamowicz M; Bolard P; Quantin C
    Stat Med; 2005 Dec; 24(24):3887-909. PubMed ID: 16320267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parametric models for accelerated and long-term survival: a comment on proportional hazards.
    Frankel P; Longmate J
    Stat Med; 2002 Nov; 21(21):3279-89. PubMed ID: 12375304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying Cox regression to competing risks.
    Lunn M; McNeil D
    Biometrics; 1995 Jun; 51(2):524-32. PubMed ID: 7662841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of surgical treatment for non-small cell lung cancer of 20 mm or less in diameter.
    Iwasaki A; Shirakusa T; Yoneda S; Makimoto Y; Enatsu S; Hamada T
    Thorac Cardiovasc Surg; 2004 Oct; 52(5):293-7. PubMed ID: 15470611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional form diagnostics for Cox's proportional hazards model.
    León LF; Tsai CL
    Biometrics; 2004 Mar; 60(1):75-84. PubMed ID: 15032776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
    Huang JZ; Liu L
    Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer.
    Kim DW; Shyr Y; Chen H; Akerley W; Johnson DH; Choy H
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1029-36. PubMed ID: 15913910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.